Core Viewpoint - The China Securities Regulatory Commission (CSRC) has announced additional requirements for the overseas issuance and listing of Kefu Medical, emphasizing the need for clarification on the company's domestic subsidiaries and their qualifications for conducting certain business activities [1] Group 1: Company Overview - Kefu Medical is recognized as one of the largest home medical device companies in China, ranking second among all home medical device enterprises based on sales in 2024 according to Frost & Sullivan [1] - As of June 30, 2025, Kefu Medical operates 738 self-owned stores in China, with 689 of these being "Jianer Hearing" service centers, covering over 135 cities in the country [1] Group 2: Regulatory Requirements - The CSRC requires Kefu Medical to further explain whether its domestic subsidiaries comply with the regulations regarding overseas issuance of securities [1] - The company must provide details on its subsidiaries' business scope, particularly in "advertising publishing" and "advertising design and agency," including whether they have obtained the necessary qualifications and licenses [1] - Additionally, Kefu Medical is asked to clarify its subsidiaries' operations in "internet information services" and other business areas, ensuring compliance with relevant regulations [1]
新股消息|可孚医疗拟港股IPO中国证监会要求说明境内子公司是否存在相关规定的不得境外发行上市情形